NCT04220203 2025-06-26Treatment Protocol of Tucatinib With Capecitabine and Trastuzumab in Patients With Unresectable Previously Treated HER2+ Breast CancerSeagen Inc.Approved for marketing
NCT00338247 2016-04-06EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast CancerNovartisApproved for marketing